IV THROMBOLYSIS(rt PA-Alteplase) AS TREATMEANT IN SEVERE COVID ARDS:A case series. - rt-PAC19SRDS

COLUMBIA ASIA REFERRAL HOSITA0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: J80- Acute respiratory distress syndromeHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Overview

Phase: N/A
Intervention: Not specified
Conditions: Health Condition 1: J80- Acute respiratory distress syndromeHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor: COLUMBIA ASIA REFERRAL HOSITA
Status: Not Yet Recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Observational

Investigators

Sponsor

COLUMBIA ASIA REFERRAL HOSITA

Eligibility Criteria

Inclusion Criteria

•Severe COVID \-19 ARDS (pao2:fio2 ratio \<100\) who are admitted to IC

Exclusion Criteria

•Prior intracrainial hemorrhage
•Iaschemic stroke within 3 months
•Uncontrolled hypertension(BP \>180/110\)
•Major surgery within 3 months prior
•Non compressible vascular puncture

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

N/A

Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic StrokeIschemic Stroke

NCT03192332Insel Gruppe AG, University Hospital Bern410

Recruiting

N/A

Effectiveness of intravenous thrombolysis in patients with mild stroke symptomsDiseases of the nervous system

KCT0000842Seoul National University Bundang Hospital1,396

Active, Not Recruiting

N/A

sistemic thrombolysis with Alteplase between 3-4.5 hours in acute ischaemic stroke. Evaluation of clinical efficacy - NDIschaemic strokeMedDRA version: 9.1Level: PTClassification code 10014498MedDRA version: 9.1Level: PTClassification code 10043647

EUCTR2009-012654-20-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Active, Not Recruiting

Phase 1

Comparing three different treatment options for acute clots in the pulmonary vesselsAcute Pulmonary Embolism, intermediate high risk (visible impact on right ventricular structure and function, and biochemical markers og myocardial damage according to the European Society of Cardiology Guidelines)MedDRA version: 21.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

EUCTR2017-005075-91-DKCopenhagen University Hospital Rigshospitalet210

Completed

N/A

Study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurololidine-citrate and heparin catheter locks in patients treated with haemodialysis

ISRCTN07668752ancashire Teaching Hospitals NHS trust (UK)106